Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT02973828
Eligibility Criteria:
Inclusion Criteria:
* All volunteers must undergo and satisfy MRI safety screening
* Non-patient volunteers must have no known (or suspected) significant medical condition and be 18 years of age
* Patient volunteers must have histologically confirmed invasive carcinoma of the tumour/target sites listed in this protocol and be under the care of a Clinical Oncologist at the Royal Marsden NHS Foundation Trust or The Christie NHS Foundation Trust and patients be planned to receive radiotherapy to target site to be imaged
* All volunteers must be willing and able to provide informed consent/assent for the study
* Paediatric patient volunteers between the ages of 3 and 18 years, will have consent provided by his or her legal guardian who is 18 years of age
* Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
Exclusion Criteria:
Any conditions that would be a contra-indication to MRI including:
* Failure to satisfy the MRI safety screening
* Implanted pacemakers and/or pacing wires
* Cochlear implants
* Programmable hydrocephalus shunts
* Implanted neurostimulation systems
* Implanted drug infusion pumps
* Ferromagnetic implants And additional conditions that may place volunteers at increased risk from MRI procedures including:
* Known susceptibility to seizures or migraines
* Fever, reduced thermal regulatory capabilities or increased sensitivity to raised body temperature (for example pregnant women)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT02973828
Study Brief:
Protocol Section:
NCT02973828